894
LOW- AND HIGH-DOSE RIFAXIMIN VERSUS LOW-DOSE RIFAXIMIN COMBINED WITH N-ACETYLCYSTEINE FOR TREATING DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED PROOF-OF-CONCEPT TRIAL
Date
May 5, 2025
Explore related products in the following collection:
